Bernard Mallee: Coronavirus shows our reliance on biopharma

The industry is devoting all its resources to finding a vaccine, but we should not be complacent about the need to invest in future innovation, says Bernard Mallee

AS the health authorities deal with the first case of Covid-19 in Ireland, the global biopharmaceutical industry is racing to find a treatment for the potentially deadly virus.